Tradestie Institutional Equity Comparison Engine

SAX vs AHR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AHR Overall Edge

AHR Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Healthcare REIT, Inc. (AHR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SAX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AHR at 63.9x Forward P/E and 6.8% operating margin (+29.4% YoY). In options structure, SAX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AHR sits in UNCLASSIFIED (27th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AHR
SAX N/M vs AHR 63.9x Fwd P/E
Growth & Margin Winner AHR
Op Margin N/A vs 6.8% ยท YoY N/A vs +29.4%
Momentum & Technical Winner AHR
1Y -0.9% vs +16.3% ยท 52W Pos 25% vs 86%
Options & Structure Winner AHR
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (27th %ile IV)
SAX US Equity
SAX
Institutional Equity
$24.43
+0.37% 1D
Market Cap N/A
1M Return -2.28%
1Y Return -0.89%
Forward P/E N/M
Unified AI Score
52.0 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 55.0
AHR NYSE
American Healthcare REIT, Inc.
Real Estate Investment Trusts
$57.54
-0.12% 1D
Market Cap $13.4B
1M Return +7.75%
1Y Return +16.27%
Forward P/E 63.9x
Unified AI Score
44.7 / 100 HOLD
Tech 33.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SAX -0.89% AHR +16.27% Spread: +2.77 pp (AHR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SAX TTM Op. Margin: N/A AHR TTM Op. Margin: 6.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SAX vs AHR. Trailing 12-month operating profitability (SAX N/A vs AHR 6.8%) and valuation multiples (SAX N/M vs AHR 63.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SAX (2) vs AHR (8)
Institutional Metric SAX AHR Criterion Row Winner
Market Capitalization Scale N/A $13.4B Larger Scale AHR
Trailing P/E Ratio Valuation N/M 117.6x Lower Multiple AHR
Forward P/E Ratio Valuation N/M 63.9x Lower Multiple AHR
Revenue Growth (YoY) Growth N/A +29.4% Higher Growth AHR
Operating Margin (TTM) Profitability N/A 6.8% Higher Margin AHR
Net Profit Margin Profitability N/A 3.6% Higher Margin AHR
Return on Equity (ROE) Capital Efficiency N/A 2.3% Higher ROE AHR
52-Week Range Position Momentum 25% ($24โ€“$26) 86% ($45โ€“$60) Stronger Trend AHR
Beta / 30D Volatility Risk Regime 0.10ฮฒ ยท 8% Vol 0.02ฮฒ ยท 28% Vol Lower Realized Risk SAX
Unified Institutional Score Composite Signal 52.0 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite SAX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SAX vs AHR Buy Guide
SAX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AHR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 27th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AHR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SAX nor AHR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.